ACTIVE

Stena Pharm

Financial year 2025 · closed on 31/12/2025
Net result
-5,9 k €
-174.6% YoY
Gross margin
15,2 k €
-51.1% YoY
Equity
252,5 k €
-6.4% YoY

What does Stena Pharm do?

Stena Pharm is a Private limited company incorporated in 2011. Its main activity is: Management consultancy activities. Its registered office is in Antwerpen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0834.256.121
Incorporation
03/03/2011
Legal form
Private limited company
Registered office
Veltwijcklaan 135
2180 Antwerpen · FlandreSee on map
Contributed capital
6 200,00 €
Latest accounts
31/12/2025
Signals
Solid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 14 financial years

20252024202320222021202020192018201720162015201420132012
Income statement
Gross margin15,2 k €31,2 k €31,6 k €25,7 k €27,6 k €17,4 k €39,9 k €30,9 k €32,8 k €47,1 k €69,3 k €50,9 k €58,6 k €67,9 k €
EBITDA14,9 k €30,9 k €31 k €25,3 k €27,3 k €17,1 k €39,4 k €30,7 k €31,2 k €46,2 k €68,7 k €50,3 k €57,9 k €67,1 k €
Operating result-7,6 k €9,1 k €11,6 k €10,7 k €17,2 k €9,7 k €31,1 k €21,6 k €24,3 k €26,2 k €52,4 k €33,3 k €43,5 k €42,1 k €
Net result-5,9 k €7,9 k €8,6 k €11,3 k €9,2 k €57,8 k €13,9 k €8,4 k €39,9 k €258,5 k €28,8 k €15,6 k €25,8 k €27 k €
Balance sheet
Equity252,5 k €269,7 k €268,8 k €287,2 k €276 k €267,5 k €210,5 k €197,4 k €188,9 k €159 k €90,5 k €64,7 k €49,1 k €23,2 k €
Total assets301,2 k €327,3 k €344 k €353,5 k €368,1 k €286,2 k €524 k €526,7 k €566,3 k €607,6 k €315,7 k €330 k €307,1 k €320,7 k €
Cash142,1 k €69,9 k €30,8 k €26,9 k €45,8 k €149,4 k €8,2 k €3,6 k €38,3 k €53,1 k €9,3 k €7,8 k €13,4 k €28,9 k €
Debts47,2 k €56,3 k €74 k €65,1 k €91,1 k €18,1 k €313,2 k €329,1 k €377 k €448,1 k €224,9 k €264,8 k €255,4 k €294,8 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Ingrid Grupping

Director

Active
Jean-Louis Moens

Director

Active

Ended mandates

Ingrid Grupping

Manager

Ended
Jeal-Louis Moens

Director

Ended
Jean-Louis Moens

Manager

Ended
Annual accounts

Full financial information

202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date20/07/202629/07/202525/07/202429/07/202328/07/202207/08/2021
General meeting22/06/202623/06/202524/06/202426/06/202327/06/202228/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

14 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202522/06/202620/07/2026DutchPDF
Micro model31/12/202423/06/202529/07/2025DutchPDF
Micro model31/12/202324/06/202425/07/2024DutchPDF
Micro model31/12/202226/06/202329/07/2023DutchPDF
Micro model31/12/202127/06/202228/07/2022DutchPDF
Micro model31/12/202028/06/202107/08/2021DutchPDF
Micro model31/12/201922/06/202023/07/2020DutchPDF
Micro model31/12/201824/06/201926/07/2019DutchPDF
Micro model31/12/201725/06/201831/07/2018DutchPDF
Abridged model31/12/201626/06/201728/07/2017DutchPDF
Abridged model31/12/201527/06/201624/07/2016DutchPDF
Abridged model31/12/201422/06/201503/08/2015DutchPDF
Abridged model31/12/201323/06/201425/07/2014DutchPDF
Abridged model31/12/201224/06/201331/07/2013DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Ingrid Grupping

Director

Active
Jean-Louis Moens

Director

Active

Ended mandates

Ingrid Grupping

Manager

Ended
Jeal-Louis Moens

Director

Ended
Jean-Louis Moens

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates26/05/2023
    WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates19/01/2016
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other07/03/2011
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-5,9 k €
  2. 2024
    Annual accounts 20247,9 k €
  3. 2023
    Annual accounts 20238,6 k €
  4. 2022
    Annual accounts 202211,3 k €
  5. 2021
    Annual accounts 20219,2 k €
  6. 2020
    Annual accounts 202057,8 k €
  7. 2019
    Annual accounts 201913,9 k €
  8. 2018
    Annual accounts 20188,4 k €
  9. 2017
    Annual accounts 201739,9 k €
  10. 2016
    Annual accounts 2016258,5 k €
  11. 2015
    Annual accounts 201528,8 k €
  12. 2014
    Annual accounts 201415,6 k €
  13. 2013
    Annual accounts 201325,8 k €
  14. 2012
    Annual accounts 201227 k €
  15. 03/03/2011
    IncorporationPrivate limited company